Data / Research funding / California / Amydis Diagnostics, Inc.
Amydis Diagnostics, Inc.: 6 NIH awards ($11.8M), fiscal years 2021 to 2026
Amydis Diagnostics, Inc. in La Jolla, CA is funded under 6 NIH awards ($11.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- LCXNBB1KM9K9
- State
- California
Awards
6 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis | NIH | National Institute on Aging | 2023 to 2024 | $3,420,052 | September 30, 2015 | August 31, 2025 | SARRAF, STELLA | reporter.nih.gov |
| Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients | NIH | National Institute on Aging | 2021 to 2022 | $3,033,670 | June 1, 2021 | May 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,977,682 | September 23, 2021 | August 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
| Development of a topical tracer to detect TDP43 in ALS, LATE and FTD retinas for AI-powered disease insights | NIH | National Institute on Aging | 2025 | $1,388,697 | August 15, 2022 | May 31, 2027 | SARRAF, STELLA | reporter.nih.gov |
| Development of Novel Tau Retinal Tracers for Alzheimer's Disease and other Tauopathies | NIH | National Institute on Aging | 2021 | $492,212 | September 1, 2021 | August 31, 2023 | SARRAF, STELLA | reporter.nih.gov |
| Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD | NIH | National Institute on Aging | 2022 | $458,527 | August 15, 2022 | July 31, 2024 | SARRAF, STELLA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2025 | 1 | $1,388,697 | 0 | $0 |
| 2024 | 1 | $1,715,680 | 0 | $0 |
| 2023 | 1 | $1,704,372 | 0 | $0 |
| 2022 | 3 | $2,801,423 | 0 | $0 |
| 2021 | 3 | $4,160,668 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.866 | November 6, 2026 | $350,000 | Same assistance listing 93.866 as 5 awards here |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) | RFA-AG-27-010 | NIH | 93.866 | November 10, 2026 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.866 | November 17, 2026 | $200,000 | Same assistance listing 93.866 as 5 awards here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.866 | November 23, 2026 | $375,000 | Same assistance listing 93.866 as 5 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.866 | November 24, 2026 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 5 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.866 | December 4, 2026 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.866 | January 7, 2027 | $375,000 | Same assistance listing 93.866 as 5 awards here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.866 | January 7, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.866 | January 7, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.866 | January 15, 2027 | $350,000 | Same assistance listing 93.866 as 5 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.866 | January 22, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) | RFA-DA-28-011 | NIH | 93.866 | January 26, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) | RFA-DA-28-012 | NIH | 93.866 | January 26, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.866 | January 27, 2027 | $500,000 | Same assistance listing 93.866 as 5 awards here |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | RFA-NS-24-031 | NIH | 93.866 | January 28, 2027 | $750,000 | Same assistance listing 93.866 as 5 awards here |
| BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | RFA-MH-26-170 | NIH | 93.866 | February 8, 2027 | Not listed | Same assistance listing 93.866 as 5 awards here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.